Header cover image

Danish Pharmaceuticals & Biotech Sustainable Track Record

Results

3

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

3 companies

Genmab

Market Cap: DKK 77.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,225.00

7D

-2.1%

1Y

-40.7%

ChemoMetec

Market Cap: DKK 8.0b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 458.20

7D

7.8%

1Y

55.3%

Novo Nordisk

Market Cap: DKK 1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 420.30

7D

-2.7%

1Y

-52.2%